Discussion on current problems of neoadjuvant chemoradiotherapy for esophageal carcinoma
10.3760/cma.j.cn113030-20200817-00425
- VernacularTitle:食管癌新辅助放化疗现有问题探讨
- Author:
Heyi GONG
1
;
Baosheng LI
Author Information
1. 山东省肿瘤防治研究院 山东省放射肿瘤学重点实验室 山东第一医科大学附属肿瘤医院放疗科，济南 250117
- Keywords:
Esophageal neoplasm/neoadjuvant radiochemotherapy;
Issue
- From:
Chinese Journal of Radiation Oncology
2021;30(8):759-763
- CountryChina
- Language:Chinese
-
Abstract:
Neoadjuvant chemoradiotherapy is the preferred treatment mode for the diagnosis and treatment of locally advanced operable esophageal carcinoma recommended by many guidelines. However, some problems remain to be further explored. In this article, current problems perplexing clinical practice were sorted out, aiming to provide constructive suggestions for the smooth development of neoadjuvant chemoradiotherapy for esophageal carcinoma in the future.
